Mepha Pharma AG - Emtricitabin-Tenofovir-Mepha, Filmtabletten | | 66181 | | 01 | | Emtricitabin-Tenofovir-Mepha | | Filmtabletten | | J05AR03 | | Tenofovir disoproxil and emtricitabine | | 31.03.2017 | | |
| Composition | emtricitabinum 200 mg, tenofovirum disoproxilum 245 mg ut tenofoviri disoproxili phosphas, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, hypromellosum, natrii stearylis fumaras corresp. natrium 3.55 mg, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), E 132, pro compresso obducto. | Packungsbestandteile | | Comprimés filmés | | | Principe actif | Concentr. |
---|
Emtricitabine | 200 mg | Tenofovir Disoproxil | 245 mg |
| BAG: Principe actif | Concentr. |
---|
Emtricitabine | 200 mg | Tenofovir Disoproxil | 245 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Flavum) | | | Cellulosum Microcristallinum | | | E 132 | | color. | E 171 | | color. | E 172 | | color. | Hydroxypropylcellulosum Substitutum Humile | | | Hypromellosum | | | Macrogol | 3350 | | Mannitol | | | Natrii Stearylis Fumaras | | | Poly(Alcohol Vinylicus) | | Überzug | Pro Compresso Obducto | | | Talcum | | |
| |
| |
|